Mariposa Therapeutics
Mariposa develops solutions for patients with epidermolysis bullosa simplex (EBS). Its first solution is derived from the unique chemistry and biological activity of ajoene, a metabolite of crushed garlic. Grounded on its unique expertise in ajoene chemistry and its biological activities, Mariposa has identified synthetic analogues of this small molecule that activate surrogate keratin expression, thereby functionally compensating for the genetic defect in EB simplex patients.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
4
organic / mo
Sign up free to see all 3 verified contacts at Mariposa Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- DH
David Howat
Chief Executive Officer · General Business & Management
EmailPhone - BP
Bill Pigg
Non Executive Director · General Business & Management
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Mariposa Therapeutics
2 distinct titles indexed · top 2 shown.
- 1chief executive officer
- 1non executive director
Sign up to unlock all 3 contacts at Mariposa Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Mariposa Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.